Unknown

Dataset Information

0

The validation of the Beijing version of the Montreal Cognitive Assessment in Chinese patients undergoing hemodialysis.


ABSTRACT: OBJECTIVE:Cognitive impairment is common among hemodialysis patient, but still lack adequate screening in clinical settings. The Montreal Cognitive Assessment (MoCA) is reportedly to be a sensitive screening tool for cognitive impairment, but its clinical value in patients undergoing hemodialysis is not well established. We aimed to validate the utility of the Beijing version of the MoCA (MoCA-BJ) for detecting cognitive impairment in comparison to a detailed neuropsychological battery as the gold standard. METHODS:We assessed 613 patients undergoing hemodialysis using the MoCA-BJ, the Mini-Mental State Examination (MMSE), and a comprehensive neuropsychological battery. Cognitive dysfunction was defined by the fifth version of the Diagnostic and Statistical Manual of Mental Disorders (DSM-V). Spearman's correlation and linear regression were used to estimate the performance of the MoCA-BJ and MMSE in predicting cognitive impairment. A receiver operating characteristic (ROC) curve analysis was used to evaluate the utility of various cutoffs of the MoCA-BJ and MMSE for predicting cognitive impairment. RESULTS:Cognitive impairment was diagnosed in 80.91% (496/613), 75.69% (464/613), and 61.34% (376 /613) of the patients using the DSM-V, MoCA-BJ, and MMSE, respectively. Spearman's rank correlation analysis indicated that the MoCA-BJ was significantly correlated with the neuropsychological battery (rs = 0.639, p<0.001), whereas the MMSE had a weaker correlation with the battery. The area under the ROC curve for cognitive impairment diagnosis using the MoCA-BJ was 0.891 (95% confidence interval: 0.859-0.924) while using the MMSE was 0.823 (95% confidence interval: 0.786-0.860). The optimal MoCA-BJ cutoff score in discriminating patients with and without cognitive impairment was 24 points with a sensitivity of 0.877 and specificity of 0.752. CONCLUSION:The MoCA-BJ offers good sensitivity and specificity levels in detecting cognitive impairment in hemodialysis patients. These findings support the utility of the MoCA-BJ as a screening tool for cognitive impairment in Chinese patients undergoing hemodialysis.

SUBMITTER: Tian R 

PROVIDER: S-EPMC6952078 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications

The validation of the Beijing version of the Montreal Cognitive Assessment in Chinese patients undergoing hemodialysis.

Tian Ru R   Guo Yidan Y   Ye Pengpeng P   Zhang Chunxia C   Luo Yang Y  

PloS one 20200109 1


<h4>Objective</h4>Cognitive impairment is common among hemodialysis patient, but still lack adequate screening in clinical settings. The Montreal Cognitive Assessment (MoCA) is reportedly to be a sensitive screening tool for cognitive impairment, but its clinical value in patients undergoing hemodialysis is not well established. We aimed to validate the utility of the Beijing version of the MoCA (MoCA-BJ) for detecting cognitive impairment in comparison to a detailed neuropsychological battery a  ...[more]

Similar Datasets

| S-EPMC4058117 | biostudies-other
| S-EPMC4514887 | biostudies-literature
| S-EPMC8699542 | biostudies-literature
| S-EPMC4209968 | biostudies-literature
| S-EPMC6663597 | biostudies-literature
| S-EPMC6208087 | biostudies-other
| S-EPMC8258379 | biostudies-literature
| S-EPMC5634551 | biostudies-literature
| S-EPMC7083175 | biostudies-literature
| S-EPMC7791730 | biostudies-literature